Time to progression of mantle cell lymphoma after high‐dose cytarabine‐based regimens defines patients risk for death. (8th November 2018)

• Record Type: Journal Article
• Authors: Visco, Carlo; Tisi, Maria C.; Evangelista, Andrea; Di Rocco, Alice; Zoellner, Anna‐Katharina; Zilioli, Vittorio R.; Hohaus, Stefan; Sciarra, Roberta; Re, Alessandro; Tecchio, Cristina; Chiappella, Annalisa; Morello, Lucia; Gini, Guido; Nassi, Luca; Perrone, Tommasina; Molinari, Anna L.; Fabbri, Alberto; Cox, Maria C.; Finolezzi, Erica; Ferrero, Simone; Puccini, Benedetta; Alvarez De Celis, Isabel; Arcari, Annalisa; Marino, Dario; Merli, Michele; Piazza, Francesco; Gentile, Massimo; Pelosini, Matteo; Loseto, Giacomo; Hermine, Olivier; Dreyling, Martin; Ruggeri, Marco; Martelli, Maurizio; Hoster, Eva; Vitolo, Umberto;
• Is Part Of: British journal of haematology. Volume 185:Number 5(2019)
• Page Start: 940
• Page End: 944
• Publication Date: 2018-11-08
• Subjects: mantle cell lymphoma -- cytarabine -- refractory -- prognosis -- allogeneic transplant; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; 616.15
• DOI: 10.1111/bjh.15643
• Languages: English
• ISSNs: 0007-1048